nach oben

Obesity Surgery

Erschienen in:

07.06.2019 | Review Article

Gastro-Intestinal Tract Cancers Following Bariatric Surgery: a Narrative Review

verfasst von: Reza Ebrahimi, Mohammad Kermansaravi, Alireza Khalaj, Foolad Eghbali, Ali Mousavi, Abdolreza Pazouki

Erschienen in: Obesity Surgery | Ausgabe 8/2019

Einloggen, um Zugang zu erhalten

Abstract

The association between obesity and malignancies has been identified epidemiologically. Meanwhile, the increasing global number of bariatric surgeries is reported annually; bariatric surgery’s effect on different types of cancers is not well understood. Unfortunately, nonspecific presentations and difficulties regarding investigations make diagnosis challenging. The aim of this study is to compile available data about gastro-intestinal (GI) cancers, occurring after different bariatric surgeries. Although GI cancers are considered a rare complication of obesity surgery, they do exist, and diagnosis needs a high index of suspicion.

Nur mit Berechtigung zugänglich

Angrisani L, Santonicola A, Iovino P. Gastric cancer: a de novo diagnosis after laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2014;10(1):186–7.PubMed

Menendez P, Villarejo P, Padilla D. Krukenberg tumor after gastric bypass for morbid obesity. Bariatric surgery and gastric cancer. Rev Esp Enferm Dig. 2013;105(5):296–8.PubMed

Crea N, Pata G, Di Betta E, et al. High incidence of appendix carcinoid tumors among candidates for bariatric surgery: diagnostic and therapeutic implications. Obes Surg. 2011;21(2):151–6.PubMed

Jawad A, Bar AH, Merianos D, et al. MALT lymphoma of the gastric remnant after Roux-en-Y gastric bypass. J Gastrointest Cancer. 2012;43(1):194–7.

Marino KA, Weksler B. Esophagectomy after weight-reduction surgery. Thorac Surg Clin. 2018;28(1):53–8.PubMed

Braghetto I, Martinez G, Korn O, et al. Laparoscopic subtotal gastrectomy in morbid obese patients: a valid option to laparoscopic gastric bypass in particular circumstances (prospective study). Surg Today. 2018;48(5):558–65.PubMed

Menendez P, Padilla D, Villarejo P, et al. Does bariatric surgery decrease gastric cancer risk? Hepatogastroenterology. 2012;59(114):409–12.PubMed

Sainsbury A, Goodlad RA, Perry SL, et al. Increased colorectal epithelial cell proliferation and crypt fission associated with obesity and roux-en-Y gastric bypass. Cancer Epidemiol Biomark Prev. 2008;17(6):1401–10.

Vladimirov M, Hesse U, Stein HJ. Gastric carcinoma after sleeve gastrectomy for obesity. Surg Obes Relat Dis. 2017;13(8):1459–61.PubMed

10.

Abellan I, Ruiz de Angulo D, Parrilla P. Incidental gastric gastrointestinal stromal tumor (GIST) in the excluded stomach after Roux-en-Y gastric bypass: a case report and review of the literature. Surg Obes Relat Dis. 2014;10(1):e13–4.PubMed

11.

Afshar S, Kelly SB, Seymour K, et al. The effects of bariatric surgery on colorectal cancer risk: systematic review and meta-analysis. Obes Surg. 2014;24(10):1793–9.PubMed

12.

Masrur M, Elli E, Gonzalez-Ciccarelli LF, et al. De novo gastric adenocarcinoma 1 year after sleeve gastrectomy in a transplant patient. Int J Surg Case Rep. 2016;20:10–3.PubMedPubMedCentral

13.

Rogers AM, Capen J, Galka E, et al. Tubulovillous adenoma with atypia found at gastrojejunal anastomosis 8 years after gastric bypass for morbid obesity. Surg Obes Relat Dis. 2007;3(5):559–60.PubMed

14.

van de Vrande S, Himpens J, Leman G. Adenocarcinoma of the gastric pouch after Roux-en-Y gastric bypass: a new technique for en bloc resection and reconstruction. Surg Obes Relat Dis. 2017;13(10):1793–5.PubMed

15.

Tao W, Konings P, Hull MA, et al. Colorectal cancer prognosis following obesity surgery in a population-based cohort study. Obes Surg. 2017;27(5):1233–9.PubMed

16.

Morris L, Beketaev I, Barrios R, et al. Colon adenocarcinoma after jejunoileal bypass for morbid obesity. J Surg Case Rep. 2017;2017(11):rjx214.PubMedPubMedCentral

17.

Burton Jr JR, Katon R. Anterograde colonoscopy: per oral diagnosis of colon cancer with an enteroscope in a man with a jejunoileal bypass. Gastrointest Endosc. 2003;57(7):982–3.PubMed

18.

Voss S, Russell T. Carcinoma as a possible complication of jejunoileal bypass operation. West J Med. 1984;141(5):686.PubMedPubMedCentral

19.

McFarland RJ, Talbot RW, Woolf N, et al. Dysplasia of the colon after jejuno-ileal bypass. Br J Surg. 1987;74(1):21–2.PubMed

20.

Sylvan A, Sjolund B, Janunger KG, et al. Colorectal cancer risk after jejunoileal bypass: dysplasia and DNA content in longtime follow-up of patients operated on for morbid obesity. Dis Colon Rectum. 1992;35(3):245–8.PubMed

21.

Papakonstantinou A, Moustafellos P, Terzis I, et al. Gastric cancer occurring after vertical banded gastroplasty. Obes Surg. 2002;12(1):118–20.PubMed

22.

Zirak C, Lemaitre J, Lebrun E, et al. Adenocarcinoma of the pouch after silastic ring vertical gastroplasty. Obes Surg. 2002;12(5):693–4.PubMed

23.

Sweet WA. Linitis plastica presenting as pouch outlet stenosis 13 years after vertical banded gastroplasty. Obes Surg. 1996;6(1):66–70.PubMed

24.

Allen JW, Leeman MF, Richardson JD. Esophageal carcinoma following bariatric procedures. JSLS. 2004;8(4):372–5.PubMedPubMedCentral

25.

de Roover A, Detry O, de Leval L, et al. Report of two cases of gastric cancer after bariatric surgery: lymphoma of the bypassed stomach after Roux-en-Y gastric bypass and gastrointestinal stromal tumor (GIST) after vertical banded gastroplasty. Obes Surg. 2006;16(7):928–31.PubMed

26.

Jain PK, Ray B, Royston CM. Carcinoma in the gastric pouch years after vertical banded gastroplasty. Obes Surg. 2003;13(1):136–7.PubMed

27.

Melstrom LG, Bentrem DJ, Salvino MJ, et al. Adenocarcinoma of the gastroesophageal junction after bariatric surgery. Am J Surg. 2008;196(1):135–8.PubMed

28.

Snook KL, Ritchie JD. Carcinoma of esophagus after adjustable gastric banding. Obes Surg. 2003;13(5):800–2.PubMed

29.

Hackert T, Dietz M, Tjaden C, et al. Band erosion with gastric cancer. Obes Surg. 2004;14(4):559–61.PubMed

30.

Korswagen LA, Schrama JG, Bruins Slot W, et al. Adenocarcinoma of the lower esophagus after placement of a gastric band. Obes Surg. 2009;19(3):389–92.PubMed

31.

Stroh C, Hohmann U, Urban H, et al. Gastric cancer after laparoscopic adjustable gastric banding. Obes Surg. 2008;18(9):1200–2.PubMed

32.

Stauffer JA, Mathew J, Odell JA. Esophageal adenocarcinoma after laparoscopic gastric band placement for obesity. Dis Esophagus. 2011;24(1):E8–10.PubMed

33.

Szymanski D, Durczynski A, Strzelczyk J. Two-staged surgery for metastatic liver tumor in morbidly obese individual-left hemihepatectomy following placement of laparoscopic adjustable gastric band. Obes Surg. 2011;21(2):267–71.PubMed

34.

Graca SA, Costa S, Ferreira J, et al. Port--site metastases following bariatric surgery. BMJ Case Rep. 2011;2011

35.

Orlando G, Pilone V, Vitiello A, et al. Gastric cancer following bariatric surgery: a review. Surg Laparosc Endosc Percutan Tech. 2014;24(5):400–5.PubMed

36.

Scheepers AF, Schoon EJ, Nienhuijs SW. Esophageal carcinoma after sleeve gastrectomy. Surg Obes Relat Dis. 2011;7(4):e11–e2.PubMed

37.

Küper MA, Königsrainer I, Schmidt D, et al. Morbid obesity and subsequent pancreatic cancer: pylorus-preserving pancreatoduodenectomy after laparoscopic sleeve gastrectomy. Obes Surg. 2009;19(3):385–8.PubMed

38.

Khitin L, Roses RE, Birkett DH. Cancer in the gastric remnant after gastric bypass: a case report. Curr Surg. 2003;60(5):521–3.PubMed

39.

Escalona A, Guzman S, Ibanez L, et al. Gastric cancer after Roux-en-Y gastric bypass. Obes Surg. 2005;15(3):423–7.PubMed

40.

Trincado MT, del Olmo JC, Garcia Castano J, et al. Gastric pouch carcinoma after gastric bypass for morbid obesity. Obes Surg. 2005;15(8):1215–7.PubMed

41.

Corsini DA, Simoneti CA, Moreira G, et al. Cancer in the excluded stomach 4 years after gastric bypass. Obes Surg. 2006;16(7):932–4.PubMed

42.

Vanek VW, Catania M, Triveri K, et al. Retrospective review of the preoperative biliary and gastrointestinal evaluation for gastric bypass surgery. Surg Obes Relat Dis. 2006;2(1):17–22.PubMed

43.

Nguyen NT, Kim E. Consideration for esophagectomy in patients with prior bariatric surgery. Obes Surg. 2016;26(4):727–9.PubMed

44.

Watkins BJ, Blackmun S, Kuehner ME. Gastric adenocarcinoma after Roux-en-Y gastric bypass: access and evaluation of excluded stomach. Surg Obes Relat Dis. 2007;3(6):644–7.PubMed

45.

Csendes A. Roux-en-Y after gastric bypass. Arch Surg. 2008;143(8):808. author replyPubMed

46.

Khithani AS, Curtis DE, Galanopoulos C, et al. Pancreaticoduodenectomy after a Roux-en-Y gastric bypass. Obes Surg. 2009;19(6):802–5.PubMed

47.

Kuruba R, Jawad M, Karl RC, et al. Technique of resection of esophageal adenocarcinoma after Roux-en-Y gastric bypass and literature review of esophagogastric tumors after bariatric procedures. Surg Obes Relat Dis. 2009;5(5):576–81.PubMed

48.

Court I, Zissman P, Rosenthal RJ. Diagnosis and treatment of Zollinger Ellison syndrome in a morbidly obese patient after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2010;6(6):714–7.PubMed

49.

Sourianarayanane A, Mukewar SS, Upchurch BR, et al. Double-balloon enteroscopy enabled the diagnosis of duodenal adenocarcinoma in a patient with Roux-en-Y gastric bypass surgery presenting with chronic anemia. Gastrointest Endosc. 2011;73(4):837–8.PubMed

50.

Kulaylat AN, Sahajwani S, Staveley-O'Carroll KF, et al. Reconstructive options for gastroesophageal junction adenocarcinoma after Roux-en-Y gastric bypass. J Thorac Cardiovasc Surg. 2013;146(5):1296–8.PubMed

51.

Courtney MJ, Chattopadhyay D, Rao M, et al. Diffuse large B-cell lymphoma (DLBCL) in the bypassed stomach after obesity surgery. Clin Obes. 2014;4(2):116–20.PubMed

52.

Nau P, Rattner DW, Meireles O. Linitis plastica presenting two years after elective Roux-en-Y gastric bypass for treatment of morbid obesity: a case report and review of the literature. Surg Obes Relat Dis. 2014;10(2):e15–7.PubMed

53.

Magge D, Holtzman MP. Gastric adenocarcinoma in patients with Roux-en-Y gastric bypass: a case series. Surg Obes Relat Dis. 2015;11(5):e35–e8.PubMed

54.

Haenen FW, Gys B, Moreels T, et al. Linitis plastica of the bypassed stomach 7 years after Roux-en-Y gastric bypass: a case report. Acta Chir Belg. 2017;117(6):391–3.PubMed

55.

Wu CC, Lee WJ, Ser KH, et al. Gastric cancer after mini-gastric bypass surgery: a case report and literature review. Asian J Endosc Surg. 2013;6(4):303–6.PubMed

56.

Lord RV, Edwards PD, Coleman MJ. Gastric cancer in the bypassed segment after operation for morbid obesity. Aust N Z J Surg. 1997;67(8):580–2.PubMed

57.

Raijman I, Strother SV, Donegan WL. Gastric cancer after gastric bypass for obesity. Case report. J Clin Gastroenterol. 1991;13(2):191–4.PubMed

58.

Babor R, Booth M. Adenocarcinoma of the gastric pouch 26 years after loop gastric bypass. Obes Surg. 2006;16(7):935–8.PubMed

59.

Fernández EL-T, González IA, Luis HD, et al. Carcinoid syndrome misdiagnosed as a malabsorptive syndrome after biliopancreatic diversion. Obes Surg. 2007;17(7):989–92.

60.

López-Tomassetti Fernández EM, Hernández Hernández JR, Jorge VN. Right colon carcinoma infiltrating the alimentary limb in a patient with biliopancreatic diversion. Int Surg. 2014;99(4):354–8.PubMedPubMedCentral

61.

Adami GF, Papadia FS, Marinari GM, et al. Does biliopancreatic diversion carry increased risk for colorectal cancer? A cohort study. Obes Surg. 2008;18(2):212–5.PubMed

62.

Bristol J, Wells M, Williamson R. Adaptation to jejunoileal bypass promotes experimental colorectal carcinogenesis. Br J Surg. 1984;71(2):123–6.PubMed

63.

Olubuyide I, Bristol J, Williamson R. Goblet cell changes during intestinal adaptation to azoxymethane and enteric bypass in the rat. Br J Cancer. 1985;51(3):383.PubMedPubMedCentral

64.

Balsiger BM, Muru MM, Mai J, et al. Gastroesophageal reflux after intact vertical banded gastroplasty: correction by conversion to Roux-en-Y gastric bypass. J Gastrointest Surg. 2000;4(3):276–81.PubMed

65.

Chebib I, Beck P, Church N, et al. Gastric pouch adenocarcinoma and tubular adenoma of the pylorus: a field effect of dysplasia following bariatric surgery. Obes Surg. 2007;17(6):843–6.PubMed

66.

De Roover A, Detry O, Desaive C, et al. Risk of upper gastrointestinal cancer after bariatric operations. Obes Surg. 2006;16(12):1656–61.PubMed

67.

Povoski SP, Chang WW. Gastric schwannoma found incidentally 19 years after a horizontal gastroplasty for morbid obesity. Obes Surg. 2001;11(6):762–5.PubMed

68.

Ovrebø K, Hatlebakk JG, Viste A, et al. Gastroesophageal reflux in morbidly obese patients treated with gastric banding or vertical banded gastroplasty. Ann Surg. 1998;228(1):51.PubMedPubMedCentral

69.

Forsell P, Hallerbäck B, Glise H, et al. Complications following Swedish adjustable gastric banding: a long-term follow-up. Obes Surg. 1999;9(1):11–6.PubMed

70.

Kant P, Perry SL, Dexter SP, et al. Mucosal biomarkers of colorectal cancer risk do not increase at 6 months following sleeve gastrectomy, unlike gastric bypass. Obesity (Silver Spring). 2014;22(1):202–10.

71.

Yuval JB, Elazary R. The true incidence of gastric GIST: an update. Obes Surg. 2018;28(6):1787PubMed

72.

Yuval JB, Khalaileh A, Abu-Gazala M, et al. The true incidence of gastric GIST—a study based on morbidly obese patients undergoing sleeve gastrectomy. Obes Surg. 2014;24(12):2134–7.PubMed

73.

Papadia FS, Scopinaro N. Gastric cancer and Roux-en-Y gastric bypass. Obes Surg. 2006;16(11):1552.PubMed

74.

Rossidis G, Browning R, Hochwald SN, et al. Minimally invasive esophagectomy is safe in patients with previous gastric bypass. Surg Obes Relat Dis. 2014;10(1):95–100.PubMed

75.

Harper JL, Beech D, Tichansky DS, et al. Cancer in the bypassed stomach presenting early after gastric bypass. Obes Surg. 2007;17(9):1268–71.PubMed

76.

Sun C, Jackson CS, Reeves M, et al. Metastatic adenocarcinoma of the gastric pouch 5 years after Roux-en-Y gastric bypass. Obes Surg. 2008;18(3):345–8.PubMed

77.

Inoue H, Rubino F, Shimada Y, et al. Risk of gastric cancer after Roux-en-Y gastric bypass. Arch Surg. 2007;142(10):947–53.PubMed

78.

Ghanem M, Teixeira AF, Jawad MA. Resection of the excluded stomach due to severe bleeding immediately after Roux-en-Y gastric bypass in a patient with Lynch syndrome: a case report. Surg Obes Relat Dis. 2017;13(5):e21–e3.PubMed

79.

Mahawar KK, Borg C-M, Kular KS, et al. Understanding objections to one anastomosis (mini) gastric bypass: a survey of 417 surgeons not performing this procedure. Obes Surg. 2017;27(9):2222–8.PubMed

80.

Bruzzi M, Chevallier J-M, Czernichow S. One-anastomosis gastric bypass: why biliary reflux remains controversial? Obes Surg. 2017;27(2):545–7.PubMed

81.

Carbajo MA, Luque-de-León E, Jiménez JM, et al. Laparoscopic one-anastomosis gastric bypass: technique, results, and long-term follow-up in 1200 patients. Obes Surg. 2017;27(5):1153–67.PubMed

82.

Chevallier JM, Arman GA, Guenzi M, et al. One thousand single anastomosis (omega loop) gastric bypasses to treat morbid obesity in a 7-year period: outcomes show few complications and good efficacy. Obes Surg. 2015;25(6):951–8.PubMed

83.

Mahawar KK. Reviews on one anastomosis gastric bypass. Obes Surg. 2016;26(11):2788.PubMed

84.

Mottin CC, Cruz RP, Gomes Thome G, et al. Carcinoid tumors and morbid obesity. Obes Surg. 2009;19(2):247–9.PubMed

85.

Keshishian A, Hamilton J, Hwang L, et al. Carcinoid tumor and bariatric surgery. Obes Surg. 2002;12(6):874–5.PubMed

86.

Aminian A, Schauer PR, Brethauer SA. Malignant gastric carcinoid tumor and morbid obesity. Surg Obes Relat Dis. 2014;10(6):1237.PubMed

87.

Erim T, Colak Y, Szomstein S. Gastric carcinoid tumor after laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2015;11(6):e51–2.PubMed

88.

Kassir R, Lointier P, Breton C, et al. Postoperative finding of gastric neuroendocrine tumor in a patient undergoing a mini gastric bypass: points to consider. Surg Obes Relat Dis. 2014;10(5):1009–11.PubMed

Titel: Gastro-Intestinal Tract Cancers Following Bariatric Surgery: a Narrative Review
verfasst von: Reza Ebrahimi
Mohammad Kermansaravi
Alireza Khalaj
Foolad Eghbali
Ali Mousavi
Abdolreza Pazouki
Publikationsdatum: 07.06.2019
Verlag: Springer US
Erschienen in: Obesity Surgery / Ausgabe 8/2019
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI: https://doi.org/10.1007/s11695-019-04007-y

Neu im Fachgebiet Chirurgie

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Wie sieht der OP der Zukunft aus?

04.05.2024 DCK 2024 Kongressbericht

Der OP in der Zukunft wird mit weniger Personal auskommen – nicht, weil die Technik das medizinische Fachpersonal verdrängt, sondern weil der Personalmangel es nötig macht.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Recycling im OP – möglich, aber teuer

02.05.2024 DCK 2024 Kongressbericht

Auch wenn sich Krankenhäuser nachhaltig und grün geben – sie tragen aktuell erheblich zu den CO₂-Emissionen bei und produzieren jede Menge Müll. Ein Pilotprojekt aus Bonn zeigt, dass viele Op.-Abfälle wiederverwertet werden können.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2019

The Impact of Staple Line Reinforcement Utilization on Bleeding and Leak Rates Following Sleeve Gastrectomy for Severe Obesity: a Propensity and Case–Control Matched Analysis

Internal Hernia and Roux-en-Y Gastric Bypass: Should the Routine Closure of Defects Still Be a Matter of Debate?

Ivor Lewis Oesophagectomy for a Distal Adenocarcinoma of the Oesophagus 10 Years After Roux-en-Y Gastric Bypass (RYGB)

Correction to: Incidence and Risk Factors for Cholelithiasis After Bariatric Surgery

Impact of Preoperative Anemia on Postoperative Kidney Function Following Laparoscopic Bariatric Surgery

Longitudinal Impacts of Gastric Bypass Surgery on Pharmacodynamics and Pharmacokinetics of Statins

Update Chirurgie